JNJ

Johnson & Johnson (NYSE: JNJ) FY 2026 Corporate Conference

Johnson & Johnson (NYSE: JNJ) FY 2026 Other Release

Johnson & Johnson (NYSE: JNJ) Q4 2025 Earnings Call dated Jan. 21, 2026 Corporate Participants: Darren Snellgrove — Vice President…

Johnson & Johnson (NYSE: JNJ) Q2 2025 Earnings Call dated Jul. 16, 2025 Corporate Participants: Darren Snellgrove — Vice President,…

Johnson & Johnson (NYSE: JNJ) Q3 2025 Earnings Call dated Oct. 14, 2025 Corporate Participants: Darren Snellgrove — Vice President…

Johnson & Johnson (NYSE: JNJ) reported its fourth quarter 2025 earnings results today. Reported sales increased 9.1% year-over-year to $24.56…

Earnings Preview Overview Johnson & Johnson approaches earnings as a focused healthcare company following the consumer health separation. Results will…

Johnson & Johnson (NYSE: JNJ) reported its second quarter 2025 earnings results today. Reported sales increased 5.8% year-over-year to $23.7…

Johnson & Johnson (NYSE: JNJ) is set to publish its December-quarter report on January 22, amid expectations for mixed results.…

Johnson & Johnson (NYSE: JNJ) reported its third quarter 2024 earnings results today. Reported sales increased 5.2% year-over-year to $22.5 billion.…